Cargando…
cGMP kinase I, cardiac hypertrophy and PDE inhibition
Autores principales: | Patrucco, Enrico, Lukowski, Robert, Rybalkin, Sergei, Beavo, Joe, Hofmann, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363176/ http://dx.doi.org/10.1186/1471-2210-11-S1-O19 |
Ejemplares similares
-
cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013) -
Rescue of cGMP kinase I and the cause of premature death
por: Hofmann, Franz, et al.
Publicado: (2009) -
Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy
por: Rybalkin, Sergei D, et al.
Publicado: (2013) -
Molecular targets for PDE inhibitor-mediated improvement of cardiac dysfunction in the mdx mouse?
por: Adamo, Candace M, et al.
Publicado: (2011) -
cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009)